Volume 80, Issue 5 pp. 798-802
Research Article
Full Access

Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998–2003

Licel de los Angeles Rodríguez Lay

Corresponding Author

Licel de los Angeles Rodríguez Lay

Institute for Tropical Medicine “Pedro Kourí” (IPK), Havana, Cuba

Institute for Tropical Medicine, “Pedro Kouri” Institute for Tropical Medicine, Department of Virology, Director WHO/PAHO Collaborator Center for the Study of Viral Diseases, Head of the National Reference Laboratory on Viral Hepatitis, P.O. Box 601, Marianao 13, Havana City, Cuba.===Search for more papers by this author
Ariel Quintana

Ariel Quintana

Department of Physiology, University of the Saarland, Homburg, Germany

Search for more papers by this author
María Caridad Montalvo Villalba

María Caridad Montalvo Villalba

Institute for Tropical Medicine “Pedro Kourí” (IPK), Havana, Cuba

Search for more papers by this author
Gilda Lemos

Gilda Lemos

Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba

Search for more papers by this author
Marité Bello Corredor

Marité Bello Corredor

Institute for Tropical Medicine “Pedro Kourí” (IPK), Havana, Cuba

Search for more papers by this author
Aidonis Gutiérrez Moreno

Aidonis Gutiérrez Moreno

Institute for Tropical Medicine “Pedro Kourí” (IPK), Havana, Cuba

Search for more papers by this author
Pablo Aguiar Prieto

Pablo Aguiar Prieto

Ministry of Public Health, Havana, Cuba

Search for more papers by this author
María G. Guzmán

María G. Guzmán

Institute for Tropical Medicine “Pedro Kourí” (IPK), Havana, Cuba

Search for more papers by this author
David Anderson

David Anderson

Macfarlane Burnet Institute for Medical Research and Public Health, Victoria, Australia

Search for more papers by this author
First published: 21 March 2008
Citations: 39

Abstract

Viral hepatitis ranks as the fifth cause of morbidity for infectious diseases in Cuba. Epidemics are observed frequently in the population, the hepatitis A virus being the main agent responsible for such epidemics. Previous reports also confirmed the circulation of the hepatitis E virus. From 1998 to 2003, 258 serum samples were collected by the Reference Laboratory on Viral Hepatitis during 33 outbreaks of acute viral hepatitis as well as from 39 sporadic clinical cases. Sera were tested for anti-HAV and anti-HEV IgM by EIA. Overall of the 33 outbreaks studied sera from 12 (36.4%) were positive for anti-HAV IgM only, from 7 (21.2%) were positive for anti-HEV IgM only, and from 14 (42.4%) were positive for antibodies to both viruses. Individually of the 258 sera collected, 137 (53.1%) were positives for anti-HAV IgM, 20 (7.8%) were positives for anti-HEV IgM, 33 (12.8%) were positives for both markers and 68 (26.4%) were negative to both. Of the clinical cases, 4 (10.3%) were positives for anti-HAV IgM, 13 (33.3%) were positives for anti-HEV IgM and 5 (12.8%) were positives for both markers. Seventeen (43.6%) sera were negatives for all viral hepatitis markers available (A–E). A high positivity for HEV was found in outbreaks tested with the kit produced by CIGB. In particular HEV seems to infect individuals of all ages. The results demonstrate the co-circulation of and co-infection with two enterically transmitted viruses; however a higher positivity was observed for anti-HAV than to anti-HEV (53.1% vs. 7.8%) in outbreaks. J. Med. Virol. 80:798–802, 2008. © 2008 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.